Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial.

MLA

Chan, Kam Wa, et al. “Add-on Astragalus in Type 2 Diabetes and Chronic Kidney Disease: A Multi-Center, Assessor-Blind, Randomized Controlled Trial.” Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, vol. 130, July 2024, p. 155457. EBSCOhost, https://doi.org/10.1016/j.phymed.2024.155457.

APA

Chan, K. W., Kwong, A. S. K., Tsui, P. N., Chan, G. C. W., Choi, W. F., Yiu, W. H., Cheung, S. C. Y., Wong, M. M. Y., Zhang, Z.-J., Tan, K. C. B., Lao, L., Lai, K. N., & Tang, S. C. W. (2024). Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 130, 155457. https://doi.org/10.1016/j.phymed.2024.155457

Chicago

Chan, Kam Wa, Alfred Siu Kei Kwong, Pun Nang Tsui, Gary Chi Wang Chan, Wing Fai Choi, Wai Han Yiu, Simon Chi Yuen Cheung, et al. 2024. “Add-on Astragalus in Type 2 Diabetes and Chronic Kidney Disease: A Multi-Center, Assessor-Blind, Randomized Controlled Trial.” Phytomedicine : International Journal of Phytotherapy and Phytopharmacology 130 (July): 155457. doi:10.1016/j.phymed.2024.155457.